Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer (Q44513206)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer |
scientific article |
Statements
1 reference
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer (English)
1 reference
Altorki NK
1 reference
Keresztes RS
1 reference
Port JL
1 reference
Libby DM
1 reference
Korst RJ
1 reference
Flieder DB
1 reference
Ferrara CA
1 reference
Yankelevitz DF
1 reference
Subbaramaiah K
1 reference
Pasmantier MW
1 reference
Dannenberg AJ
1 reference
1 July 2003
1 reference
1 reference
Identifiers
1 reference